Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 114,902 shares at $5.09 ($572K) on 2020-03-09, disclosed to the SEC on 2020-03-13.
Seasonal sale ($572k) by Chief Executive Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.09 | 20,909 | $106K | 18.6% |
| 2 | $5.09 | 20,909 | $106K | 18.6% |
| 3 | $4.92 | 36,542 | $180K | 31.4% |
| 4 | $4.92 | 36,542 | $180K | 31.4% |
| Total | $4.98 avg | 114,902 | $572K | 100% |
| Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |
| STML | SELL | 2019-06-28 | $1.3M | — | Filing → |